Design. This is a structured evidence-based review of all available studies on the relationship between chronic pain and sleep problems as defined by the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) category of sleep disorder due to a general medical condition.
Introduction
Thirty per cent of the general population define themselves as having a sleep problem and 50% of adults report problems with sleep at some time [1] . However, in samples of chronic pain patients (CPPs), 50-88.9% [2] [3] [4] [5] [6] define themselves as having a sleep problem. As such, a number of narrative reviews [7] [8] [9] have concluded that there is an association between chronic pain and sleep problems.
The association of pain and sleep problems has also become evident in populations that were not identified as suffering from chronic pain. In an analysis of crosssectional data from the 1991 Canadian General Social Survey, Sutton et al. [10] found that while subjects with chronic medical illnesses generally had increased likelihood of having insomnia (trouble going to sleep or staying asleep), the highest odds ratios (ORs) for insomnia were found for pain-related conditions compared with conditions that are not as strongly characterized by pain, such as allergy, circulatory disease, etc. For example, 38% of patients with rheumatic disease experienced insomnia (OR = 2.45; 95% confidence interval = 2.22 to 2.72) compared with 28% of patients with allergy (OR = 1.35; 95% confidence interval = 1.23 to 1.49). Sutton et al. [10] also found that insomnia was more likely to be experienced in the presence of pain in general: 44% of responders who had pain reported insomnia, while only 19% of those with no pain reported insomnia. Additionally, increasing pain severity was associated with increasing risk for insomnia: Insomnia was reported by 19% of respondents reporting mild pain (OR = 2.28), by 42% of those reporting moderate pain (OR = 2.99), and by 58% of those reporting severe pain (OR = 5.73). Similar results have been reported for the very old. In a cross-sectional analysis of 641 subjects, Giron et al. [11] reported that poor self-rated health, depression, and pain were associated with the presence of sleep problems. In a multivariate analysis of these data, factors significantly related to sleep problems were female gender, depression, and pain [11] . Children have also been investigated for this issue in a community sample of 569 subjects (average age 10.5 years). In Bruusgaard et al. [12] , in a logistic regression analysis, sleep problems were demonstrated to be associated with mental distress and pain. Finally, for a large community sample (18,900), in a logistic regression analysis it was found that backache, limb pain, headache, and joint/ articular disease all made a strong independent contribution to complaints of sleep problems [13] .
The above research indicates that pain may indeed be associated with perceived sleep problems. However, as this research is based on self-reported sleep problems, some authors have questioned its validity [9] . Polysomnography is an objective method of documenting a sleep disorder. Here, reviewers [7, 14, 15] have reported that: 1) acute pain following various surgical procedures is associated with reduced and fragmented sleep and diminished amounts of slow wave and rapid eye movement (REM) sleep and 2) in chronic pain, the specific nature of the sleep disorder is not as clear, but generally is characterized by reduced sleep efficiency and altered sleep architecture (increased wakefulness and stage 1 nonrapid eye movement sleep).
These are perhaps the reasons why the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition
(DSM-IV) [16] addressed pain in its section on sleep disorders. The (DSM-IV) [16] organizes sleep disorders into four major categories according to 1) presumed etiology; 2) primary sleep disorders; 3) sleep disorders related to a mental disorder; substance induced sleep disorders; and 4) sleep disorders related to a general medical condition. The primary sleep disorders are divided into dyssomnias (e.g., narcolepsy, breathing related sleep disorder [sleep apnea]): and parasomnias (e.g., sleepwalking disorder). Sleep disorders due to a general medical condition involve "a prominent complaint of sleep disturbance that results from the direct physiological effects of a general medical condition on the sleep-wake system [16] ." Here DSM-IV [16] lists pain from musculoskeletal disease (e.g., fibromyalgia) as some of the general medical conditions that can cause this type of sleep disorder. It is therefore the purpose of this evidence-based structured review (described below) to determine the strength and consistency of the evidence for the hypothesis that pain is etiologically associated with the sleep problem in CPPs. The DSM-IV [16] criteria for sleep disorder due to a general medical condition are utilized as inclusion criteria to select studies for this review. Studies addressing primary sleep disorders, sleep disorders related to a mental disorder, and substance-induced sleep disorders will therefore be excluded from this review. To the authors' knowledge, this is the first structured evidence-based review in this area of research.
Methods
Relevant references were located by the following procedure. MEDLINE, Psychological Abstracts, Science Citation Index, and the National Library of Medicine Physician Data Query databases were reviewed utilizing the following subject headings: sleep, sleep disorder, disordered sleep, sleep problems, disrupted sleep, insomnia, sleep quality, sleep patterns, sleep disturbances, sleep physiology, polysomnography, sleep quality, sleep disruption, and sleep interference. Each of these was sequentially exploded with the medical subject heading (MESH) "pain." Each term was exploded for subheadings in MESH and all retrieved references reviewed. The searches were not restricted to the English language and conducted back to 1966, except for Science Citation Index, which was conducted back to 1974. The upper limit of each search was 2006. A manual search was also performed using key pain journals, pain meeting abstracts, and textbooks. Pain 1981 Pain , 1984 Pain , 1987 Pain , 1990 Pain , 1993 Pain , 1996 Pain , 1999 Pain , 2002 Pain , and 2005 1993 . In addition, a special search was conducted (as above) for any references relating to the psychopharmacological treatment of chronic pain and improvement in sleep. One-hundred and forty-six references were found and subjected to a cursory review. Studies were chosen for detailed review if they were not excluded through the use of the inclusion criteria listed below. Inclusion criteria were: any study where the relationship between sleep problems and pain was investigated in some way. Studies were then excluded from this group according to the following criteria. This review focused on the DSM-IV [16] category of sleep disorders due to a general medical condition and only one category within that general category: sleep disorders allegedly secondary to chronic pain. As such, studies were excluded if they addressed diagnoses for which a clear case could not be made after examining a description of the patients in the study that the patients were suffering from chronic pain. These then were the following types of sleep/pain studies: 1) cancer [ [32] . In addition, two of the DSM-IV [16] criteria for sleep disorder due to a general medical condition were applied both as study exclusion criteria and quality criteria (discussed below). These two criteria are: the sleep disturbance is not better accounted for by another mental disorder, for example, depression and the disturbance does not meet criteria for a primary sleep disorder such as narcolepsy or breathing related sleep disorder, etc. Thus, studies which utilized CPPs with identified sleep disorders (not pain related) were excluded, for example, sleep disordered breathing [33] . Finally, as pointed above, the DSM-IV [16] recognizes substanceinduced sleep disorders. Thus, studies where CPPs were on drugs that could interfere with sleep were excluded. In addition, a number of studies were found where sleep improved when pain was improved. With these studies, another exclusion criterion was added: studies were excluded if the drug utilized (including opioids) [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] to improve pain and thereby improve sleep had sedative properties. This was done in order to ensure that if these studies were included, the improvement in sleep could be attributed to pain improvement rather than the sedative properties of the drug. Finally, one study [48] was excluded where two drugs were utilized for pain, but one of them was an opioid with potential sedative effects. Of the original 146 references, 105 were excluded through the use of the above criteria. The remaining 41 studies [3] [4] 6, [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] were reviewed in detail and sorted into six groupings: studies utilizing multivariate analysis (Table A1) ; studies utilizing a prospective paradigm (Table A2) ; studies utilizing path analysis (Table A3) ; studies utilizing correlational analysis (Table A4) ; studies utilizing univariate analysis and comparison groups (Table A5) ; and studies utilizing analgesic nonsedating drugs to treat pain with resultant effect on sleep variables (Table A6) . It is to be noted that some studies fitted into more than one grouping or addressed two issues of relevance to this review in one grouping. These studies were then utilized more than once and when that was done, they are delineated by an asterisk in the tables.
Research information from these studies was then abstracted into tabular form. Tables A1 to A6 were organized according to the above groupings. These tables were arranged to present the author, year, design, type of study, study question, sample size, type of pain, sleep measure utilized, control for depression if any, pain measure, statistical analysis, results, type of evidence (according to Table 1 ), quality score, and comments.
The quality of the studies was categorized according to the systems developed by and reported by Hoogendoorn et al. [87] and De Vet et al. [88] . These researchers developed and tested a list of criteria to be used to assess methodological quality of prospective, historical cohort, and case control studies. For details of how these criteria were developed, the reader is referred to the original studies [87, 88] . Twelve (1-12) criteria were selected from their lists that were appropriate to the studies utilized (Table A7) . Hoogendoorn et al. [87] described 23 criteria of which many were not appropriate to the topic of this review, and as such, were not used in this study. In addition to the 12 selected criteria, two criteria were added: did the study control for depression and primary sleep disorder (Table A7 ). Depression was added as a criterion as it is well known that depression is associated with sleep problems [9] and thus could serve as a potential confounder as many chronic pain patients are depressed [89] . Also the DSM-IV [16] criteria, for sleep disorder due to a general medical condition, which is the sleep problem under investigation here, requires the exclusion of primary sleep disorders such as narcolepsy, breathing-related sleep disorder, parasomnia, etc. Thus, the presence of a primary sleep disorder, such as narcolepsy could serve as a confounder to the objectives of this study. As such, attempts to eliminate patients from a study based on the presence of primary sleep disorder was included as a quality criterion. These two criteria were then added to the 12 Hoogendoorn [87] criteria for a total of 14. The full criteria list is presented in Table A7 . For each included study, each criterion was rated as either present/fulfilled (+), not present/unfulfilled (-), or not applicable (NA). NA was used as follows. There were basically four types of studies analyzed for quality: case control, cohort, correlational, and case series. Thus, some criteria in Table A7 pertained only to case control studies, while others applied only to cohort studies, etc. As such, NA was used if the criterion in question pertained to another type of study other than the one being reviewed. In addition, NA was used when that criterion did not pertain to the study in question, for example, no need for control for depression. NA was not used when information was not available or not described [90] . Under those circumstances, a negative was assigned [90] . A negative was also assigned if the item did not meet the preselected criteria [90] . Each study was rated independently for each criterion by the senior author (D.F.) and another author (V.M.). Both raters chose either a positive, negative, or NA for each criterion for each study selected for detailed review. The assigned categorizations by DF and VM for each selected study were then compared in a meeting. Any discrepancies in the categorizations were resolved by mutual agreement. This resulted in a final decision as to whether each criterion received a negative, positive, or NA categorization. Categorizations were then summarized and placed into tabular format (Table A7 ). A quality score was obtained by counting the number of positives obtained. This score was divided by 14 (the total number of criteria) minus the number of NAs and multiplied by 100, which gave the percentage quality score.
Studies scoring less than 50% historically have been rated as "low quality" [90] . These studies are usually not utilized to arrive at conclusions about a review topic. For the purposes of this review, we arbitrarily set the acceptable quality score at 60% in order to avoid marginal studies. Studies scoring less than 60% were then not utilized in arriving at a conclusion about the reviewed topic.
The senior author was the one who independently abstracted the data into Tables A1-A6. However, data abstraction was checked independently by V.M. Any discrepancies were resolved by mutual agreement. In addition, V.M. checked the classifications of the reviewed studies, that is, whether the reviewed study was a cohort, case control, etc. Any discrepancies in this classification were also resolved by mutual agreement.
The categorization of the type of evidence the study represented was based on the guidelines developed by the Agency for Health Care Policy and Research (AHCPR) for categorizing the levels of evidence represented by reviewed studies (Table 1 Evidence Guidelines) [91] . Studies were categorized I through V according to this scheme. In this categorization, I represents a metaanalysis of well-designed, controlled studies and V represents a case report or clinical example. This categorization was also independently arrived at by the senior author and V.M. Any discrepancies were again resolved by mutual agreement in a meeting format.
The strength and consistency of the research evidence in each study grouping (Tables A1-A6 ) was then categorized according to the AHCPR consistency of evidence guidelines [91] developed for this purpose (Table 1) . These guidelines allow the researcher to categorize the reviewed evidence as being consistent, generally consistent, inconsistent, or demonstrating little or no evidence for supporting the hypothesis under study. In using these categorization guidelines, only studies attaining a score of 60% or greater were used. Categorizations according to these guidelines (Table 1) were performed by the senior author and reviewed by V.M. Any discrepancies were later resolved by mutual agreement.
Finally, data from Tables A1-A6 were formatted into a  summary table (Table 2 ). This last table was designed to summarize the overall findings of the structured review by listing the following according to the different study groupings: number of studies for each grouping; type of evidence in per cent for each grouping; average quality score for each grouping; findings as a per cent of the total Table 1 Multivariate Analysis (Table A1) 21 Type III 100%
86.5 77.2% (16/21) studies found that pain predicted the presence of a sleep problem.
B
Prospective (Table A2) 3 Type III 100%
69.6 100% (3/3) found that poor night's sleep followed previously elevated pain levels.
A Path Analysis (Table A3) 2 Type III 100%
82.1 100% (2/2) studies found that sleep disruption is mediated by pain.
Too few studies to generate a consistency rating
Correlation between pain severity and sleep? (Table A4) 4 Type IV 100%
83.6 100% (4/4) studies found that pain severity correlated with disturbed sleep.
A Univariate analysis using comparison groups (Table A5) 90.0 100% (6/6) studies found that drugs with analgesic properties improve sleep as they improve pain.
A number of studies for each grouping; and according to the above findings, the strength/consistency of the evidence for that grouping according to the AHCPR guidelines (Table 1 ) [91] .
Results
Of the 41 studies, none had quality scores below 60% (Tables A1-A6) . Twenty-one studies [3, [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] utilized multivariate analysis to address the sleep/pain relationship. One hundred per cent of the studies were Type III with an average quality score of 86.5% (Table 2) . Here, 77.2% of the studies found that pain predicted the presence of a sleep problem. Based on these observations and according to the AHCPR guidelines (Table 1) , the consistency of this evidence was B (generally consistent) ( Table 1) .
Three studies [69] [70] [71] utilized a prospective paradigm to address the potential relationship between pain and sleep (Table A2) . One hundred per cent of the studies were Type III with an average quality score of 69.6% (Table 2) . One hundred per cent of these studies demonstrated that a poor night's sleep followed previously elevated pain levels. According to the AHCPR guidelines (Table 1) , the consistency of this evidence was A (generally consistent findings (Table 2) .
Two studies [72, 73] utilized path analysis to address the potential relationship between pain/sleep. (Table A3 ). Both studies in this group were Type III with an average quality score of 82.1% (Table 2 ). Both studies found that sleep disruption is mediated by pain (Table 2 ). Here however, there were too few studies to generate a consistency rating (Table 2) .
Four studies [4, 51, 74, 75] utilized correlational analysis to address the potential relationship between pain/sleep (Table A4) . One hundred per cent of these studies were Type IV, having an average quality score of 83.6% (Table 2) . One hundred per cent of these studies found that pain severity correlated with disrupted sleep. According to AHCPR guidelines (Table 1) , the consistency of this evidence was A (consistent findings) ( Table 2 ).
Thirteen studies [3, 6, 52, 58, 59, 67, 74, 76, [76] [77] [78] [79] [80] utilized univariate analysis to address the potential relationship between sleep/pain (Table A5) . One hundred per cent of these studies found that an association between pain and sleep, such as more sleep problems in pain patients vs comparison groups, indicated that pain may have an effect on sleep. One hundred per cent of these studies were Type IV, having an average quality score of 85.9%. According to the AHCPR guidelines (Table 1) , the consistency of this evidence was A (consistent findings) ( Table 2) .
Six studies [81] [82] [83] [84] [85] [86] answered the question of whether analgesic drugs without sedative properties improve sleep (Table A6) . Here, 83.3% of the studies were Type II and 16.6% Type III. The average quality score was 90.0%. One hundred per cent of these studies demonstrated that these drugs improve sleep as they improve pain. According to the AHCPR guidelines (Table 1) , the consistency of this evidence was A (consistent finding) ( Table 2) .
Overall, of the 49 total reports (eight studies utilized more than once), five (10.2%) were Type II, 28 (57.1%) were Type III, and 16 (32.6%) were Type IV. The overall average quality score for the 49 reports was 85.2%. Of a total of 49 reports (eight studies were utilized more than once), 44 (89.7%) directly or indirectly supported the association between pain and sleep being in the direction of pain mediating the sleep problem ( Table 2 ). According to AHCPR guidelines (Table 1) , the consistency of this evidence was A (consistent, multiple studies). Finally, of these 41 studies, 20% or 48.7% controlled for depression in some way, but only 2% or 4.8% controlled for the presence of a primary sleep disorders (narcolepsy, breathing related disorder, circadian rhythm sleep disorder, parasomnias, etc.).
Discussion
This structured evidence-based review has attempted to answer the question on whether pain is etiologically related to the presence of sleep problems as defined by the DSM-IV category of sleep disorder due to a general medical condition, i.e.: chronic : pain. In that regard, the results of this review indicate that there is consistent multiple study evidence (rated as A) that indicates that chronic pain may be etiologically related to a sleep problem utilizing criteria from the DSM-IV [16] category of sleep disorders due to a general medical condition. At issue then is whether there is polysomnography evidence in the literature that physiologically pain could induce some form of sleep problem. It appears that there is evidence to that effect. In a study [92] of healthy adults without pain or sleep disorder or sleep complaints, 13 individuals were subjected to noxious stimuli during all stages of sleep. It was found that pain during sleep trigerred a sleep awaking response over all stages of sleep and not only in light sleep [91] . In another similarly designed study [93] , nociceptive heat stimulation evoked a moderate level of cortical arousal during sleep. This research indicates that pain during sleep can result in a night of poor sleep and thereby indirectly supports the results of this study, but also presents a physiological explanation for the problem.
What are the possible confounders to the results of this review? The first major potential confounder is evidence that actual sleep problems may cause hyperalgesia while sleep itself has an antinociceptive effect [7] . This evidence comes from three types of studies. First, in fibromyalgia patients, pain threshold correlates with subjective sleep quality [94] . Second, a number of studies have demonstrated that sleep restriction in healthy pain-free normal sleepers will cause hyperalgesia on pain stimulation testing subsequent to the sleep restriction [95] [96] [97] [98] . Similarly, sleep interruption during REM sleep also causes hyperalgesia on pain stimulation testing [97, 99] . Third, sleep restriction appears to cause elevations in interleukin-6, which in turn is positively correlated with changes in estimations of pain-related symptoms in healthy young subjects who are normal sleepers [100] . Thus, the hyperalgesia issue secondary to sleep deprivation could have served as a major confounder to the results of this review. However, closer examination of Table 2 reveals two study groupings (prospective and do drugs with analgesic properties that are nonsedating improve sleep?), which are of such design, that they circumvent this potential confounder. Both of these groupings had the highest strength/consistency rating (A) supporting the concept that pain mediates the sleep problem rather than vice versa. As such, sleep problems causing hyperalgesia may not have served as a major confounder to the results of this evidence-based structured review. However, in spite of this, these results do not allow an absolute conclusion that pain mediates the sleep problems in CPPs if they do not have a primary sleep disorder such as sleep apnea or the other exclusion criteria utilized. This is because these results do not preclude the relationship from being bi-directional, that is, pain causing sleep problems, which in turn accentuating pain or a sleep problem pre-pain causing pain, then accentuating the sleep problem. These results do however indicate that pain could be an etiological factor for the sleep problem in CPPs (as defined here) whether the relationship is bi-directional or not.
A second potential confounder is that early sleep research studies noted that certain pain syndromes such as fibromyalgia and some chronic pain syndromes were associated with the alpha-EEG sleep anomaly [98, 101] . As such, early authors postulated that the alphaelectroencephalography anomaly was of etiological significance in producing the pain complaints among patients with chronic pain. Recent studies to test this hypothesis have either compared chronic pain patients to primary insomniacs for the frequency of this anomaly [102] or examined consecutive patients with sleep problems for this anomaly and then evaluated those with the anomaly for the presence of pain [101] . In the first study, the prevalence of this anomaly was no greater in the chronic pain groups [102] . In the second study, 5% of the consecutive patients had this anomaly, but only 40% of these patients had pain [101] . Both of these sleep studies then indicate that this anomaly is not exclusively found in CPPs and is not necessarily associated with pain. Thus, it is unlikely that it has etiological significance to the development of chronic pain. However, the fact that this sleep anomaly is found in some CPPs would indicate that studies in this area should have controlled for sleep disorders as a potential cause of the sleep problem in the chronic pain patients. This is the reason why this issue was identified as a study quality characteristic. As noted in the results, only 4.8% of the studies included in this evidence based review controlled for this issue. Thus, this problem could potentially have confounded the results of this review.
A third potential confounder is that historically sleep problems have been noted to be associated with depression [103, 104] 
Conclusions
The results of this evidence-based structured review indicate that for the pain sleep association, the CPPs' sleep problem as defined here could be pain mediated. However, this conclusion does not preclude a bi-directional relationship between pain and sleep problems. 
